AMR Action Fund head aims to boost innovation, funds for new antibiotics
28 January 2022
CIDRAP News spoke with AMR Action Fund CEO Henry Skinner, PhD, about the current state of antibiotic development, the need to fix the broken market for new antibiotics, and how to build a sustainable pipeline. The following excerpts from the conversation have been lightly edited for length and clarity.
Further reading: CIDRAP
Author(s): Chris Dall
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
